The FDA has approved Leqembi Iqlik (lecanemab-irmb) subcutaneous weekly starting dose, enabling fully at-home treatment initiation for early Alzheimer disease.
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena ...
FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.
State Attorney General Alan Wilson carried the GOP primary runoff for governor over Lt. Gov. Pamela Evette. President Donald Trump endorsed Evette before the initial June 9 primary, but Trump also ...
South Korea’s government and top tech companies are committing $1 trillion to several flagship megaprojects that could bolster global memory chip supply, build new AI data centers, and spur commercial ...
Zacks Investment Research on MSN
Biogen wins FDA approval for subcutaneous starter dose of Leqembi
Shares of Biogen BIIB rose nearly 5% yesterday after the company announced that the FDA approved a subcutaneous (SC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results